PIK3CA and cancer: The PI3K and Ras/MAPK pathways demonstrate a high level of signaling crosstalk, and accumulating preclinical data, in both cancer cell lines and murine models, suggest that concurrent inhibition of both pathways may successfully prevent cancer progression [10–13].